Newton Charles W. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$111,620.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Newton Charles W.

According to the SEC Form 4 filings, Newton Charles W., being in a position of

  1. director at Keros Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1101 share for $11,197,
    over all time since 2026-06-11, has bought 0 shares, and sold 1101 share for $11,197.

Biography of Newton Charles W.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $11,1972100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleKeros Therapeutics, Inc.
KROS
director
551
0.0017%
$10.30$5,675+5.75%
2026-06-11SaleKeros Therapeutics, Inc.
KROS
director
550
0.0017%
$10.04$5,522+10.1%
2025-08-21SaleLyell Immunopharma, Inc.
LYEL
Chief Financial Officer
1,453
0.0075%
$10.54$15,320+67.89%
2025-08-12SaleLyell Immunopharma, Inc.
LYEL
Chief Financial Officer
136
0.0009%
$10.34$1,406+69.16%
2025-08-11SaleLyell Immunopharma, Inc.
LYEL
Chief Financial Officer
131
0.0008%
$10.53$1,379+69%
2025-03-17PurchaseLyell Immunopharma, Inc.
LYEL
Chief Financial Officer
200,000
0.0731%
$0.56$111,620+26.98%
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.